ACTA NEUROPATHOLOGICA, published by Springer, is a leading journal in the fields of cellular and molecular neuroscience, clinical neurology, and pathology, recognized for its exceptional quality and impactful research. With an impressive impact factor and currently ranked in the Q1 tier across multiple categories in 2023, this journal serves as a premier platform for the dissemination of groundbreaking findings in neuropathology. The journal's robust Scopus rankings highlight its influence, standing at #2 in Pathology and Forensic Medicine and #5 in Clinical Neurology. Since its inception in 1961, ACTA NEUROPATHOLOGICA has provided crucial insights into neurological diseases and disorders, contributing significantly to the advancement of medical science. Aimed at researchers, practitioners, and students alike, this journal fosters a deeper understanding of neurological conditions and encourages innovative approaches within the field. It is essential reading for anyone dedicated to unraveling the complexities of the nervous system.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, published by Oxford University Press Inc, stands as a pivotal resource for advancing research and knowledge in the domains of neuropathology and experimental neurology. Established in 1942, this esteemed journal has expanded its influence, as evidenced by its Q1 rankings in both Neurology (clinical) and Pathology and Forensic Medicine, along with its strong placement in Cellular and Molecular Neuroscience. With an emphasis on innovative research and clinical practices, it caters to a diverse audience, including researchers and clinicians dedicated to understanding neurological disorders through a multidisciplinary lens. While not open access, this journal provides access to cutting-edge studies that are pivotal in shaping the future of medical science and pathology. Researchers benefit from its rigorous peer-review process, ensuring the publication of high-caliber work that meets the evolving demands of the field.

The Journal of Korean Neurosurgical Society, with its ISSN 2005-3711 and E-ISSN 1598-7876, stands as a paramount resource in the field of neurosurgery, bridging clinical practice and cutting-edge research in both neurology and multidisciplinary neuroscience. Published by the Korean Neurosurgical Society, this open-access journal has been committed to disseminating invaluable knowledge to the global scientific community since its establishment in 1972. Located in Seoul, South Korea, the journal underscores its prominence with impressive quartile rankings—Q3 in Neurology (Clinical), Q3 in Neuroscience (Miscellaneous), and Q2 in Surgery for 2023. Its standing in Scopus rankings further emphasizes its impact, with a ranking of #195/551 in Medicine: Surgery and #235/400 in Medicine: Neurology (Clinical). By fostering a platform for innovative findings and advancements in surgical techniques, the Journal of Korean Neurosurgical Society aims to support professionals, researchers, and students alike in their pursuit of excellence and knowledge in neurosurgery and related fields, ensuring a brighter future for patient care and scientific inquiry.

Brain and Spine is a premier academic journal published by ELSEVIER, dedicated to advancing the fields of neuroscience and neurology. With its unique focus on the complex interactions between brain function and spinal health, this journal serves as an essential resource for researchers, clinicians, and students alike. Though currently lacking an official impact factor, its ranking within Scopus highlights its relevance, placing it in the 25th percentile for neuroscience (miscellaneous) and the 23rd percentile within neurology, indicating that while it is a developing journal, it holds potential for significant contributions to the field. Operating under open-access principles, it aims to disseminate valuable findings widely, ensuring that novel insights into neurological health are accessible to a global audience. Brain and Spine seeks to foster interdisciplinary collaboration and innovation, making it an invaluable platform for those striving to enhance our understanding of the brain and spinal cord's intricate functions and interdependencies.

Neurosurgical Focus, an esteemed journal published by the American Association of Neurological Surgeons, stands at the forefront of neurosurgical research and clinical practice. With its ISSN 1092-0684, this peer-reviewed publication has made a significant impact in the fields of Medicine, Neurology, and Surgery, consistently ranking in the top quartile (Q1) across these categories based on the 2023 metrics. The journal, which spans a rich temporal landscape from 2000 to 2024, offers a platform for disseminating vital research findings, insightful reviews, and innovative surgical techniques. While it is not open access, its high Scopus rankings—40th out of 551 in Medicine & Surgery and 97th out of 400 in Neurology—highlight its broader influence and the quality of research it curates. As an essential resource for researchers, clinicians, and students, Neurosurgical Focus is dedicated to advancing the field of neurosurgery and fostering intellectual discourse within the community.

Therapeutic Advances in Neurological Disorders, published by SAGE Publications Ltd, is a leading open access journal dedicated to the advancement of knowledge in the field of neurology. Since its inception in 2008, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for the dissemination of high-quality research that improves the understanding and treatment of neurological disorders. With a commendable impact factor and ranked Q1 in multiple categories, including Neurology and Pharmacology for 2023, it exemplifies excellence in scholarly contributions. The journal's Scope encompasses a wide array of topics, providing insights that are pivotal for clinical practice and pharmacological development. Additionally, with its commitment to open access since 2017, Therapeutic Advances in Neurological Disorders ensures that its research reaches a global audience, fostering collaboration and innovation in neurological science.

Journal of Cancer is a premier, peer-reviewed academic journal published by IVYSPRING INTERNATIONAL PUBLISHING that focuses on advancing the field of oncology. With an impact factor reflecting its significant contributions, this journal ranks in the 80th percentile of medical journals pertaining to oncology, positioning it at #79 out of 404 in Scopus. Since its inception in 2010, the journal has embraced an Open Access model, ensuring that groundbreaking research reaches a global audience without barriers. Based in Australia, the journal addresses a wide array of topics within cancer research, catering to researchers, healthcare professionals, and students committed to enhancing their understanding of the complexities of cancer. Amidst evolving challenges in oncology, the Journal of Cancer serves as a vital platform for disseminating innovative findings, fostering collaboration, and promoting informed decisions that can lead to improved cancer outcomes worldwide.

NEURO-ONCOLOGY, a leading journal published by OXFORD UNIVERSIT PRESS INC, is at the forefront of research in the intersection of neurology and oncology, with contributions spanning from 1999 to 2024. With a recognized impact reflected in its strong ranking, holding Q1 status in Cancer Research, Neurology (Clinical), and Oncology categories, NEURO-ONCOLOGY provides a vital platform for the dissemination of groundbreaking studies and advancements in brain tumor research and treatment. The journal ranks impressively within the 99th percentile in clinical neurology and 96th percentile in oncology, highlighting its significance and influence within the field. Accessible through institutional subscriptions, it serves as a valuable resource for researchers, healthcare professionals, and students seeking to stay informed of the latest developments, therapeutic strategies, and scientific discussions in neuro-oncology.

Brain Tumor Pathology is a pivotal peer-reviewed journal published by SPRINGER JAPAN KK, focusing on the intricate and evolving field of brain tumor research. Established in 1997, the journal serves as a crucial platform for disseminating research findings, clinical studies, and reviews that advance our understanding of brain tumors and their pathology. With a notable impact factor, it ranks in the Q2 and Q3 quartiles in multiple categories, including Cancer Research, Medicine (miscellaneous), Neurology (clinical), and Oncology, reflecting its significance in enhancing scientific discourse and clinical practice. The journal is indexed by major databases, making it accessible to a wide audience of researchers, clinicians, and students who are dedicated to unraveling the complex mechanisms of brain tumors. Although it does not currently offer open access, its comprehensive articles and studies contribute to the vital conversation on brain tumor pathologies, treatment prospects, and innovation in the field. Researchers and professionals alike will find the insights and advancements presented in Brain Tumor Pathology indispensable for guiding future studies and improving clinical outcomes.

Frontiers in Oncology is a premier open access journal dedicated to advancing the field of oncology through innovative research and knowledge dissemination. Published by FRONTIERS MEDIA SA since 2011, this journal is based in Switzerland and holds an impressive Q2 ranking in both Cancer Research and Oncology as of 2023, highlighting its significance in the academic community. With its commitment to open access, Frontiers in Oncology ensures that vital research is readily available to researchers, healthcare professionals, and students around the globe, enhancing collaboration and fostering breakthroughs in cancer research. The journal's robust Scopus rankings further illustrate its academic influence, with notable positions in the fields of Oncology and Cancer Research. By covering a wide range of topics within oncology, this journal serves as a vital resource, supporting the rapid evolution of cancer treatment, diagnostics, and patient care strategies.